| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2009 | CN100536842C Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity |
| 09/09/2009 | CN100536841C Cyclopropyl and cyclobutyl epothilone analogs |
| 09/09/2009 | CN100536840C Combinations of anti-cancer agents |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/09/2009 | CN100536838C Tamsulosin hydrochloride cotrolled-releasing tablet preparation and preparing method thereof |
| 09/09/2009 | CN100536837C Application of scyllo inositol for preparation of diagnosing reagent |
| 09/09/2009 | CN100536836C Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 09/09/2009 | CN100536835C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 09/09/2009 | CN100536833C Improved pharmaceutical formulations |
| 09/09/2009 | CN100536829C Erigeron breviscapus oral caving fast disintegration tablet and its preparation method |
| 09/09/2009 | CN100536691C Compositions containing coenzyme Q10 |
| 09/08/2009 | US7586020 Methods for determining effects of maternal treatments on offspring |
| 09/08/2009 | US7586008 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient |
| 09/08/2009 | US7586001 Nateglinide crystals |
| 09/08/2009 | US7585997 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof |
| 09/08/2009 | US7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 09/08/2009 | US7585985 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 09/08/2009 | US7585977 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 09/08/2009 | US7585973 chemical synthesis for forming a conjugate of anticancer drug with folic acid; chemotherapy drug |
| 09/08/2009 | US7585966 Directed against accessible regions in the telomerase ribonucleoprotein; cancer |
| 09/08/2009 | US7585952 Fully human miniantibody (scFv) called Erbicin, specific for the receptor ErbB2; antitumor; transmembrane tyrosine kinase receptor |
| 09/08/2009 | US7585897 Modified release formulations of a bupropion salt |
| 09/08/2009 | US7585896 Composition for the prevention and treatment of kidney dysfunctions and diseases |
| 09/08/2009 | US7585895 prostaglandin agonists such as 3-(3-{(1R,2S,3R,5R)-5-Chloro-3-hydroxy-2-[4-(1-hydroxy-hexyl)-phenyl]-cyclopentyl}-propyl)-benzoic acid; used for the treatment of vision defects, inflammatory bowel disease and Crohn's disease |
| 09/08/2009 | US7585894 4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof |
| 09/08/2009 | US7585893 Anti-cancer composition comprising DMXAA or related compound |
| 09/08/2009 | US7585892 Compound for promoting the growth of neural cells |
| 09/08/2009 | US7585891 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides |
| 09/08/2009 | US7585890 One or more purified flavonoids and purified menthol, in a state of purity such that the purified menthol has a direct antiviral effect in vitro on rhinovirus in WISH cells, or potentiates the antiviral effect in vitro of human interferon - alpha -2b (Intron A) on rhinovirus in WISH cells |
| 09/08/2009 | US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585886 Pyrrolidine derivative or salt thereof |
| 09/08/2009 | US7585884 Pleconaril; reduced side effects |
| 09/08/2009 | US7585883 For mast cell related diseases such as autoimmune diseases; Hashimoto's thyroiditis, hemolytic anemia, atrophic gastritis of pernicious anemia, encephalomyelitis |
| 09/08/2009 | US7585882 Phosphodiesterase 4 inhibitors |
| 09/08/2009 | US7585881 2-[5-(3-Methoxy-phenyl)-[1,2,4]oxadiazol-3-ylmethylsulfanyl]-1H-benzoimidazole, for example; useful for the inhibition of transient lower esophageal sphincter relaxations and thus for treatment of gastro-esophageal reflux disorder |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585879 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585877 Aminophenyl derivatives as selective androgen receptor modulators |
| 09/08/2009 | US7585876 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585875 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 09/08/2009 | US7585874 2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridine; 8-methyl-2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridine; high affinity and selectivity for gamma-aminobutyric acid (GABA) A alpha 5 receptor binding sites; Alzheimer's disease |
| 09/08/2009 | US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585872 Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors |
| 09/08/2009 | US7585871 Phenanthridine carbonyl phenols |
| 09/08/2009 | US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 09/08/2009 | US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors |
| 09/08/2009 | US7585868 Antagonists of a lipid kinase such as a PI3 kinase, protein tyrosine kinase, and/or protein serine-threonine kinases such as mTOR; 1-isopropyl-3-(3-methoxy-4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| 09/08/2009 | US7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one |
| 09/08/2009 | US7585866 Protein tyrosine kinase inhibitors |
| 09/08/2009 | US7585865 Protein kinase C zeta inhibition to treat vascular permeability |
| 09/08/2009 | US7585864 1,1-Dimethyl-4-(8-chloro-5,11-dihydro-[1]benzoxepino[4,3-b]pyridin-11(S)-yl)-2(R)-[[[3-(4-methyl-1H-imidazol-1yl)propyl]phenylmethyl)amino]carbonyl]-1-piperazinecarboxylate |
| 09/08/2009 | US7585863 Antitumor agents; such as (2-(4-(7-Chloro-2-quinoxalinyl)oxy)propionylamino ethansulfonic acid; {2-{4-(7-Chloro-quinoxalin-2-yloxy)-phenoxy}propionyl amino}acetic acid |
| 09/08/2009 | US7585862 Reverse-turn mimetics and method relating thereto |
| 09/08/2009 | US7585861 HIV replication inhibitors; for (multi)drug resistant HIV infection |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585859 PDE4B inhibitors and uses therefor |
| 09/08/2009 | US7585858 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins |
| 09/08/2009 | US7585857 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/08/2009 | US7585856 Resolvins: Biotemplates for novel therapeutic interventions |
| 09/08/2009 | US7585855 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof |
| 09/08/2009 | US7585854 Method for treating endometriosis |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | US7585852 Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation |
| 09/08/2009 | US7585851 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| 09/08/2009 | US7585850 Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/08/2009 | US7585848 Administration of NF- kappa B inhibitor into intervertebral disc to treat intervertebral disc degeneration, wherein NF- kappa B inhibitor is selected from decoy oligonucleotide capable of binding to and acting on DNA binding site of NF- kappa B, antisense NF- kappa B nucleic acid, and NF- kappa B siRNA |
| 09/08/2009 | US7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 09/08/2009 | US7585846 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 09/08/2009 | US7585845 Using protease inhibitor |
| 09/08/2009 | US7585839 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
| 09/08/2009 | US7585826 applying catalytic ionic salt, buffers and a mixture of a reducing coenzyme and oxidizers or sulfide, to crops, fruits, humans, protective clothing or devices and medical equipment |
| 09/08/2009 | US7585675 Antisense IL-4 inhibits viral replication in the liver, lungs, spleen, and even the lymph nodes; can be used in combination with other antiretroviral agents or vaccines |
| 09/08/2009 | US7585642 Methods for evaluating the quality of a heparin sample |
| 09/08/2009 | US7585627 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585523 Oral administering neurotransmitter with plant extract; cognition activators, sleep disorders; hypotensive agents; viricides; central nervous system disorders |
| 09/08/2009 | US7585520 Compositions containing both sedative and non-sedative antihistamines and sleep aids |
| 09/08/2009 | US7585519 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/08/2009 | US7585517 delivery system contains a solid core of rapamycin or other therapeutic agent |
| 09/08/2009 | US7585513 Aerosol containing branched block copolymers comprised of acrylic acid and alkyl acrylates and/or N-alkyl or N,N-dialkylacrylamide monomers; moisture resistance |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | US7585320 Energetically-controlled delivery of biologically active material from an implanted medical device |
| 09/08/2009 | CA2555911C Adjuvant compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/08/2009 | CA2546894C Reference standard for characterization of rosuvastatin |
| 09/08/2009 | CA2522813C 2-alkynyl-and 2-alkenyl-pyrazolo-¬4,3-e|-1,2,4-triazolo-¬1,5-c|-pyrimidine adenosine a2a receptor antagonists |
| 09/08/2009 | CA2520901C Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents |
| 09/08/2009 | CA2519919C Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 09/08/2009 | CA2518910C Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/08/2009 | CA2510933C Methods of delivering materials into the skin, and compositions used therein |
| 09/08/2009 | CA2487540C Process for the preparation of free-flowing, pulverized atorvastatin adsorbates |
| 09/08/2009 | CA2478506C Pharmaceutical formulation for the active ingredient budesonide |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |